Ashkon Software







 

VIRS - Pacer BioThreat Strategy ETF

Expense Ratio: 0.7%

VIRS ETF Stock Chart

VIRS Profile

Pacer BioThreat Strategy ETF logo

The Pacer BioThreat Strategy ETF is an exchange-traded fund that seeks to provide investors with exposure to companies that are involved in the development and manufacturing of products and services designed to protect against biological threats. The fund is managed by Pacer ETFs, an investment management company that specializes in thematic ETFs.

As of September 2021, the VIRS ETF had a net asset value of approximately $12 million and held 35 individual stocks. The fund's portfolio is comprised of companies involved in various aspects of biosecurity, such as the development of vaccines, diagnostics, and therapeutics for infectious diseases, as well as companies involved in the manufacturing of personal protective equipment (PPE) and other biosecurity-related products.

The COVID-19 pandemic has highlighted the importance of preparedness for biological threats, and the VIRS ETF is designed to provide investors with exposure to companies that are positioned to benefit from increased demand for biosecurity-related products and services.

The expense ratio for the VIRS ETF is 0.70%, which is relatively high compared to some other ETFs. However, the VIRS ETF is a niche product that offers exposure to a specific segment of the healthcare and technology industries.

Overall, the Pacer BioThreat Strategy ETF may be a suitable investment for investors seeking exposure to companies involved in the development and manufacturing of products and services designed to protect against biological threats. However, as with any investment, it is important to consider the unique risks and challenges of the healthcare and technology industries, as well as the relatively high expense ratio of the fund. Investors should also conduct their own research and consider their investment goals and risk tolerance before investing i


 

Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer